Execution on assets cannot mask a quarter of broken claims
Ola commissioned its 6 GWh cell factory and ramped dealers to 255 stores — real achievements. But revenue collapsed 39% YoY, margins were cut, and operating losses are worsening, not improving. The gap between what management claimed and what the numbers show is now too wide to ignore.
₹420 Cr
−39% YoY; 35–36K units
−₹218 Cr
OPM −51.9%; worsened QoQ
−₹362 Cr
NPM −81%; down −7.7% QoQ
On the surface, there are real wins: Ola commissioned its 6 GWh domestic cell factory on September 23, scaled dealers from zero to 255 stores in two months, and reduced net debt by ₹1,400 crore. But the quarter itself tells a different story. Revenue fell 39% year-over-year, gross margins were cut to 30% from a prior 35–40% guidance, and operating losses worsened from −₹195 crore (Q1) to −₹246 crore (Q2) despite management claims of stabilization. The company's pre-call narrative — demand-led growth, OpEx discipline, margin recovery — has collapsed under the weight of the delivered numbers.
Claims on the call vs. what the numbers show
Demand ahead of supply; can sell every vehicle produced
Revenue ₹420 Cr, down 39% YoY. Paid-order backlog ₹500–1,000 Cr (small). 4–5K units couldn't be booked due to charger constraints, implying ~40–41K 'true' demand.
Overstated
OpEx stabilized; gross margin held at 30% mark
OpEx ₹369 Cr (above ₹250–300 Cr target). Gross margin 30%, down from prior 35–40% FY27 guidance.
Contradicted
Operating EBITDA improving; meaningful cash flow improvement underway
Operating EBITDA −₹246 Cr (Q2) vs −₹195 Cr (Q1); deteriorated ₹51 Cr QoQ despite OpEx claims.
Contradicted
Dealer transition very encouraging; 300+ stores in 2 months
255 dealers live by Nov 8 (started Sept 4). Targeting 450 by Dec, 700+ by Mar 2027. Real progress, but margin-dilutive near-term.
Supported (with caveat)
Cell facility COD achieved; 6 GWh commissioned on schedule
COD achieved Sept 23. Added 3.5 GWh to 2.5 GWh existing capacity. Government extended PLI to 2031.
Supported
NMC yields mid-70s; targeting mid-80s next couple months
Mid-70s yields claimed. No credible timeline or itemized roadmap to 90%; competitor benchmarks (Tesla 3 years, Korean players couple years) not acknowledged.
Partial (vague roadmap)
Where the operating loss came from
Revenue of ₹420 crore delivered gross profit of ~₹126 crore (30% margin). OpEx of ₹369 crore — still above the ₹250–300 crore quarterly target management has been guiding for — created an operating loss of ₹218 crore (OPM −51.9%). Finance costs and other charges pushed the net loss to ₹362 crore. The quarter is loss-making, not on a one-time item, but on the core operating structure: volumes 35–36k at insufficient margin per unit.
What changed on this call vs. prior quarters
Gross margin guidance cut from 35–40% to 30%. Management now frames dealer commissions as the culprit for Q3–Q4 pressure; margin recovery promised post-stabilization.
EBITDA trajectory reversed. Q2 operating EBITDA worsened ₹51 crore QoQ despite OpEx discipline claims. Prior calls promised sequential improvement; instead, losses are accelerating.
Cell expansion roadmap extended. 6 GWh now commissioned. Management wants to stabilize for 'next couple of quarters' before moving to 20 GWh mid-term. Timeline for mid-term is vague.
Dealer channel accelerated; margin penalty acknowledged. 255 stores live (targeting 700+ by Mar 2027), but management concedes gross margin will decline Q3–Q4 due to commissions. Operating margin promised to improve thereafter.
S1Z premium launch pushed to Q4; testing underway. Timing uncertain ('might shift'). Reservations only ₹500–1,000 crore. Focus pivoted to scaling core scooter volumes, not accelerating S1Z.
The bull-bear ledger
First and only 6 GWh domestic cell factory commissioned in India; meaningful capex cycle now complete
Dealer network ramp (255 → 700+) is real execution; unlocks new geographies and reduces reliance on D2C
Net debt reduced ₹1,400 crore via equity raise and capex discipline; balance sheet de-risked
Vertical integration moat credible (BoM 15–20% lower than Ather; cell production in-house)
Revenue collapsed 39% YoY; 'demand ahead of supply' narrative demolished by numbers
Operating losses worsening QoQ despite OpEx stabilization claims; path to profitability 18+ months away at current burn
Gross margin guidance cut from 35–40% to 30%; dealer transition admittedly margin-dilutive
Cell yield roadmap to 90% lacks credible timeline; management claims couple months to mid-80s, dismisses Tesla (3 yrs) and Korean benchmarks
Management credibility on EBITDA deterioration glossed over as 'stabilization'; evasion on equity raised and S1Z timing
Ranked risks — by how much they should concern a holder
Cell yield ramp credibility and timeline
HighMid-70s to 90% yields in couple months is uncredible vs. Tesla (3 yrs), Korean (couple yrs). Delays crater the BoM advantage Ola banks on. Margin recovery entirely dependent.
Dealer transition margin recovery path
HighDealer commissions are diluting gross margin now (30% vs 35–40% guided). Recovery depends on commission reduction AND cost discipline. Management promises both; neither is proven.
Operating EBITDA and cash burn trajectory
HighEBITDA worsening QoQ despite OpEx claims. At −₹246 Cr run-rate and ₹1,800 Cr net debt, cash runway under 18 months if trend continues. GST refund (₹1,000 Cr pending) buys time, but is one-time.
Demand sustainability and volume leverage
HighRevenue −39% YoY contradicts 'demand ahead of supply'. Dealer ramp is unproven. Without volume scale, dealer margin dilution + low OpEx discipline = no path to profitability.
Profitability timeline and execution dependencies
MediumCompany is 18+ months from operating profitability. Multiple simultaneous levers (cell yields, dealer margin, OpEx to target) must align. If any slip, cash burn extends further.
How the street is positioned
The stock trades at ₹33.73, down 78.57% from its all-time high of ₹157.4 and 51.6% above the 52-week low of ₹22.25. It sits below all major moving averages (SMA20 ₹34, SMA50 ₹35.94, SMA200 ₹35.61) with RSI at 45.7 — a neutral, not oversold, signal. The drawdown suggests the market has priced in significant execution risk, but the absence of a true washout (RSI < 30) hints that a sizable shareholder base still believes in the long-term story.
Institutional ownership tells a nuanced story. FII stake declined 0.17pp to 4.56% — a retreat, albeit modest. DII ownership rose 1.47pp to 13.22%, signalling domestic institutions are picking up the dip or staying the course. Promoter shareholding held steady at 32.67%, a neutral signal (no surprise selling, no additional conviction via buyback). Bulk/block data over the past six months shows Jump Trading dominating with matched buy-sell pairs at multiple price levels (₹33–43 range) — classic market-making, nothing that signals insider accumulation or panic distribution. The street is cautious but not fleeing.
Crucially, the post-result price action (Nov 16, the latest available snapshot) shows the stock holding steady near ₹33.73, not rallying on the cell commissioning news or dealer ramp. The market is validating the fundamental read: real asset progress is being masked by deteriorating economics. Until revenue stabilizes and losses show signs of narrowing, the stock is likely to remain range-bound or drift lower.
1 · Dealer network headcount and volume contribution
Track stores live (targeting 450 by Dec, 700+ by Mar 2027) and what % of Q3 sales come via dealer channel vs. D2C. If dealer channel is real, volumes should stabilize or grow sequentially; if it cannibalizes, you'll see it in mix and ASP.
2 · Cell production ramp and gross margin stabilization
NMC yields next level (management claimed mid-80s next couple months from Q2). Watch for gross margin trend Q3 vs. Q2 (down from dealer commissions, then recovery in Q4). Without cell yield proof, margin recovery is credibility theater.
3 · Operating EBITDA trajectory and cash burn rate
The core metric. If Q3 EBITDA deteriorates further or stays negative, the 18-month profitability claim collapses. GST refund timing and amount should also clarify (₹1,000 Cr pending, 30–40% liquid near-term). Watch cash position and net debt — if it ticks back up, burn is real.
Ola Electric's Q2 is a quarter of divergent realities: execution on cell and dealers is real, but current-quarter fundamentals are deteriorating, not recovering. Revenue is down 39% year-over-year, operating losses are accelerating, and gross margin guidance was cut. The company sits 18+ months from profitability at current burn rates, dependent on simultaneous wins in cell yields, dealer margin recovery, and cost discipline — none of which are yet proven.
For holders, the question is not whether the long-term vertical integration story is *possible*; it is whether the company can reach profitability before cash runs out and whether management's execution credibility will recover. For prospective investors, the risk/reward is unfavorable until one of two things happens: (a) Q3 or Q4 delivers proof of sequential margin stabilization and loss narrowing, or (b) the stock trades lower to reflect a 2–3 year wait with material downside if execution slips.
Rating: Hold. The number to track from here is operating EBITDA — not guidance, not cell yields, but the quarterly operating cash burn. Until it narrows, the stock is likely to drift sideways or lower.
Informational and educational content only. Not investment advice.